Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Spanish lab designs selective muscarinic M3 receptor antagonists

Feb. 8, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

New series from Taisho inhibits 20-HETE production

Feb. 7, 2002

EMEA accepts vardenafil submission for treatment of ED

Feb. 6, 2002

Pharmacia licenses Nastech's nasally administered apomorphine for ED & FSD

Feb. 6, 2002

Curis reports evidence for a unique mechanism for the renal effects of BMP-7

Feb. 6, 2002

Highly effective antinephritic agent derived from linomide

Feb. 1, 2002

Preparation and use of new series of PDE5 inhibitors

Jan. 29, 2002

Chemokine CCR1 receptor antagonist effective in mouse model of renal fibrosis

Jan. 29, 2002

Vivus cleared to proceed with TA-1790 trial in erectile dysfunction

Jan. 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...